Malanghing, Esperidion B.
HRN: 20-06-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/12/2023
01/19/2023
IV
300mg
Q6h
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes